Phoenix Molecular Imaging 

Call Us:  602.368.3055

   The results of our large-scale experience with C11-Acetate were published in the January 2017 edition of the American Journal of Nuclear Medicine and Molecular Imaging.  The primary findings from the publication are that C11-Acetate PET/CT imaging demonstrates a very high detection rate for Prostate cancer recurrence (88%) and that both the PSA level and rate of PSA rise have an influence on the detection rate. C11-Acetate imaging was able to find early local or local-regional disease recurrence in a large number of men, which paved the way to additional individualized treatment options. Through support of the foundation (AMIFund.org), we are happy to be able to make this article widely available to the medical community and to the public via an open access journal  -  http://www.ajnmmi.us/files/ajnmmi0041325.pdf. 

   This core work is now being presented at various professional medical meetings and prostate cancer support symposium. 

   A joint publication with the Urological Team at the University of Southern California has been published in the January 2017 edition of the British Journal of Urology. In this study, we used C11-Acetate PET/CT imaging to help select and guide robotic lymph node dissection in Prostate Cancer recurrence. This work is part of multiple ongoing research studies exploring C11-Acetate imaging guided treatment options for those with cancer spread limited to the lymph nodes - http://onlinelibrary.wiley.com/doi/10.1111/bju.13741/full

Dr. Fabio Almeida discusses C11 Acetate PET/CT Imaging for detection of prostate cancer recurrence  - 2015 mid year PCRI conference.  35 minute presentation followed by Q&A with Dr. Mark Moyad and Dr. Almeida

Presentation at the 26th International Prostate Cancer Update in Colorado:

View the Abstract

View the Poster Presentation
-January 2016


Molecular Imaging Newsletter - C11 Acetate PET/CT Imaging
-August 2016


The Latest in Prostate Cancer Molecular Imaging
-July 2015
Dr. Almeida provides an overview of his presentation at the Radiologic Society of North America (RSNA) annual conference and insights to new technology in this area. Summarized on the PCRI blog.


Presentation at the PCRI Mid Year Conference

-April 11 2015

Molecular Imaging - PET/CT in Prostate Cancer


Presentation to USToo Support Group

-January 2014
-C-11 Acetate Positron Emission Tomography imaging for prostate cancer evaluation after biochemical relapse
-Summary: Biochemical relapse is a significant problem for a large number of prostate cancer patients. These patients experience a rising PSA after local therapy with no evidence of disease on standard imaging tests. C11-acetate PET/CT is showing usefulness in these patients by identifying the area of recurrence or area(s) of limited metastatic disease, which are potentially amenable to focal surgical treatment, radiation or cryotherapy. Over 300 patients were tested with C11-acetate PET/CT in an ongoing Phase II FDA/IND clinical study. Prostate cancer imaging and results/examples from our experience with C11-Acetate will be discussed.

Presentation at American College of Radiation Oncology
-February 2014
-Session Title: Performance characteristics of Carbon-11 Acetate Positron Emission Tomography/Computed Tomography imaging in the evaluation of recurrent prostate cancer – Interim results from the AMIC-AC-001 clinical study.

Presentation to Informed Prostate Cancer Support Group in San Diego. 
-April 2014
-C-11 Acetate Positron Emission Tomography imaging for prostate cancer evaluation after biochemical relapse.

Top Fund Raising Team for Zero Prostate Challenge Event
-December 2013
-We had 31 Team members participating

Prostate Forum of Orange County, California
-April 25, 2013
-Fullerton, California
-Presentation –  A Superior Technique to Image Recurrence of Prostate Cancer
- Fabio Almeida, M.D., Medical Director, Arizona Molecular Imaging Center

Arizona Urological Society
- 2013 Annual Meeting – Tucson Omni Hotel
- Apr.5-7, 2013
-Presentation - Carbon-11 Acetate PET/CT Imaging for Recurrent Prostate Carcinoma- Update from the Arizona Molecular Imaging Cenetr
-Fabio Almeida, Medical Director

Sponsorship for Zero Great Prostate Cancer Challenge
- Tucson, AZ
- December 2, 2012
-Top Fundraising Team

Prostate Cancer Research Institute – Annual Conference
- Los Angeles, CA
- September 7-9, 2012
-Fabio Almeida, Medical Director Presentation
-Imaging Techniques in Prostate Cancer Diagnosis

Arizona Urological Society
- 2012 Annual Meeting – Sedona Hilton Hotel
- Mar.30-Apr.1, 2012

17th Annual Scottsdale Prostate Cancer Symposium
- Scottsdale, AZ
- March 1-4, 2012

View his entire 35 minute presentation here: http://youtu.be/rUbY1aTNZKQ

Dr. Fabio Almeida provides a brief overview of C11 Acetate PET/CT Imaging for detection of prostate cancer recurrence  -September 2013 in a presentation at a New Mexico Support group.